Most insurers and pharmacy benefit managers haven't placed the cheaper version of insulin manufactured by Eli Lilly on their lists of covered drugs, according to the Financial Times.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,